CAY10729
CAY10729 (Compound 21) is a selective PAD2 inhibitor. CAY10729 inhibits neutrophil extracellular trap formation.
For research use only. We do not sell to patients.
- CAS No.: 1644666-57-8
- Formula: C19H26ClN7O3
- Molecular Weight:435.91
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
PAD2 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Neutrophil | EC50 |
985 μM
Compound: 21
|
Cytotoxicity against human neutrophils assessed as cell viability after 4 hrs by XTT assay
Cytotoxicity against human neutrophils assessed as cell viability after 4 hrs by XTT assay
|
[PMID: 25559347] |
CAY10729 (1-500 μM; 4 h) exhibits extremely low cytotoxicity toward neutrophils, with an EC50 of 985 μM[1].
CAY10729 (200 mM) inhibits neutrophil extracellular trap formation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human osteosarcoma (U2OS) cells
-
Concentration:20 μM
-
Incubation Time:72 h
-
Result:Showed no reduction in U2OS cell viability relative to DMSO-treated controls.
Chemical Information
-
CAS No. 1644666-57-8
-
Molecular Weight 435.91
-
Formula C19H26ClN7O3
-
SMILES
O=C(C1=C(C=CC=C1)C(O)=O)N[C@H](C2=NN(N=N2)C(C)(C)C)CCCNC(CCl)=N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)